SCM
EXAS

Suvretta Capital Management’s Exact Sciences EXAS Stock Holding History

Suvretta Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-94,100
Closed -$9.56M – 96
2025
Q4 		$9.56M Hold
94,100
– – 0.2% 63
2025
Q3 		$5.15M Hold
94,100
– – 0.13% 68
2025
Q2 		$5M Hold
94,100
– – 0.15% 63
2025
Q1 		$4.07M Hold
94,100
– – 0.15% 65
2024
Q4 		$5.29M Hold
94,100
– – 0.18% 63
2024
Q3 		$6.41M Hold
94,100
– – 0.21% 60
2024
Q2 		$3.98M Buy
+94,100
New +$5.18M 0.15% 59
2021
Q3 		– Sell
-487,400
Closed -$60.6M – 110
2021
Q2 		$60.6M Sell
487,400
-399,540
-45% -$47.7M 0.91% 34
2021
Q1 		$117M Buy
886,940
+275,839
+45% +$37.8M 1.73% 27
2020
Q4 		$81M Buy
+611,101
New +$73.9M 1.16% 34

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Suvretta Capital Management's EXAS Position: Q1 2026 in Review

Suvretta Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 94,100 shares — an estimated $9.56M sold.

Suvretta Capital Management first reported a position in EXAS in Q4 2020 and held it in 10 quarters. The position peaked at $117M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Suvretta Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Suvretta Capital Management sold 94,100 Exact Sciences shares in Q1 2026, an estimated $9.56M.
  • Suvretta Capital Management first reported a position in Exact Sciences in Q4 2020 and held it in 10 quarters.
  • Suvretta Capital Management's Exact Sciences position peaked at $117M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.